Zobrazeno 1 - 10
of 351
pro vyhledávání: '"Glenn Heller"'
Autor:
Rohit Thummalapalli, MD, Noura J. Choudhury, MD, Fiona Ehrich, MS, Tyler Beardslee, PharmD, Danielle Brazel, MD, Shannon S. Zhang, MD, Shelby Merchant, PharmD, Monica F. Chen, MD, Glenn Heller, PhD, Suresh S. Ramalingam, MD, Sai-Hong Ignatius Ou, MD, PhD, Kathryn F. Mileham, MD, Gregory J. Riely, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 8, Pp 100546- (2023)
Introduction: Treatment with lorlatinib for patients with advanced ALK- and ROS1-rearranged NSCLC (ALK+ and ROS1+ NSCLC) is associated with a unique set of adverse events (AEs) often requiring dose reduction. However, the impact of dose reductions on
Externí odkaz:
https://doaj.org/article/4a17b716e5554aaa9e42589db4af6e82
Autor:
Karen A. Autio, Emmanuel S. Antonarakis, Tina M. Mayer, Daniel H. Shevrin, Mark N. Stein, Ulka N. Vaishampayan, Michael J. Morris, Susan F. Slovin, Elisabeth I. Heath, Scott T. Tagawa, Dana E. Rathkopf, Matthew I. Milowsky, Michael R. Harrison, Tomasz M. Beer, Arjun V. Balar, Andrew J. Armstrong, Daniel J. George, Channing J. Paller, Arlyn Apollo, Daniel C. Danila, Julie N. Graff, Luke Nordquist, Erica S. Dayan Cohn, Kin Tse, Nicole A. Schreiber, Glenn Heller, Howard I. Scher
Publikováno v:
European Urology Open Science, Vol 34, Iss , Pp 70-78 (2021)
Background: Phase 2 trial endpoints that can be utilized in high-risk biochemical recurrence (BCR) after prostatectomy as a way of more rapidly identifying treatments for phase 3 trials are urgently needed. The efficacy of abiraterone acetate plus pr
Externí odkaz:
https://doaj.org/article/7cb29db5a1d04ef391276d51f770d34a
Autor:
Noura J. Choudhury, Antonio Marra, Jane S.Y. Sui, Jessica Flynn, Soo-Ryum Yang, Christina J. Falcon, Pier Selenica, Adam J. Schoenfeld, Natasha Rekhtman, Daniel Gomez, Michael F. Berger, Marc Ladanyi, Maria Arcila, Charles M. Rudin, Gregory J. Riely, Mark G. Kris, Glenn Heller, Jorge S. Reis-Filho, Helena A. Yu
Publikováno v:
Journal of Thoracic Oncology. 18:463-475
Preferred first-line treatment for patients with metastatic EGFR-mutant lung cancer is osimertinib, yet it is not known if patient outcomes may be improved by identifying and intervening upon molecular markers associated with therapeutic resistance.A
Autor:
Aisha N. Hasan, Ekaterina Doubrovina, Rosa Sottile, Susan Prockop, Martin G. Klatt, Glenn Heller, Annamalai Selvakumar, Lorna Barnett, Katharine C. Hsu, Richard J. O’Reilly
Publikováno v:
Blood Advances. 6:4859-4872
We established and characterized a bank of 138 CMVpp65 peptide-specific T-cell (CMVpp65CTLs) lines from healthy marrow transplant donors who consented to their use for treatment of individuals other than their transplant recipient. CMVpp65CTL lines i
Autor:
James W. Young, Allan C. Halpern, Steven T. Rosen, Babak Mehrara, Alison Moskowitz, Steven Horwitz, Kathleen J. Finn, Sneh Sharma, Sung Hee Kil, Xiwei Wu, Glenn Heller, Debra A. Goldman, Shane A. Curran, Patricia L. Myskowski, Samantha Leung, Christiane Querfeld
Numbers and ratios of dendritic cells and T cells migrated from skin explants
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::345fb8bd3841e41512867e8af6d0f5de
https://doi.org/10.1158/2326-6066.22539826
https://doi.org/10.1158/2326-6066.22539826
Autor:
Johannes L. Zakrzewski, Patrizia Mondello, Andrea Tuckett, Glenn Heller, David S. Siegel, Ali Makhdoom, Rena Feinman, Iriana Colorado, Claudia Heller, Hsiou-Chi Liou, Samedy Ouk, Janice Rateshwar, Elena Cassella, Manpreet Bariana
Supplementary Table from Inhibition of NF-κB DNA Binding Suppresses Myeloma Growth via Intracellular Redox and Tumor Microenvironment Modulation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82bbd2f8f2a9b40f1792652e1be29cf3
https://doi.org/10.1158/1535-7163.22523664.v1
https://doi.org/10.1158/1535-7163.22523664.v1
Autor:
James W. Young, Brian C. Betts, Katharine C. Hsu, Glenn Heller, David J. Chung, Sneh Sharma, Lillian R. Talbot, Erin T. St. Angelo, Justin A. Shyer, Shane A. Curran
Supplemental article file
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83cca434690cf948ceefe8b327dbb89f
https://doi.org/10.1158/2326-6066.22538822
https://doi.org/10.1158/2326-6066.22538822
Autor:
James W. Young, Brian C. Betts, Katharine C. Hsu, Glenn Heller, David J. Chung, Sneh Sharma, Lillian R. Talbot, Erin T. St. Angelo, Justin A. Shyer, Shane A. Curran
moDC stimulated NK cells retain surface expression of the gamma chain receptor despite the presence of JAK inhibitors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2da5862ec7bcdea764813cc97e095058
https://doi.org/10.1158/2326-6066.22538825
https://doi.org/10.1158/2326-6066.22538825
Autor:
Johannes L. Zakrzewski, Patrizia Mondello, Andrea Tuckett, Glenn Heller, David S. Siegel, Ali Makhdoom, Rena Feinman, Iriana Colorado, Claudia Heller, Hsiou-Chi Liou, Samedy Ouk, Janice Rateshwar, Elena Cassella, Manpreet Bariana
Supplementary Figure from Inhibition of NF-κB DNA Binding Suppresses Myeloma Growth via Intracellular Redox and Tumor Microenvironment Modulation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::005368c69395bfbc335cdc410e06f5a0
https://doi.org/10.1158/1535-7163.22523676.v1
https://doi.org/10.1158/1535-7163.22523676.v1
Autor:
James W. Young, Allan C. Halpern, Steven T. Rosen, Babak Mehrara, Alison Moskowitz, Steven Horwitz, Kathleen J. Finn, Sneh Sharma, Sung Hee Kil, Xiwei Wu, Glenn Heller, Debra A. Goldman, Shane A. Curran, Patricia L. Myskowski, Samantha Leung, Christiane Querfeld
Sections show morphologic and immunohistochemical findings of MF lesion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13ba9743eb53fad5a85254273d5c8dfd
https://doi.org/10.1158/2326-6066.22539832
https://doi.org/10.1158/2326-6066.22539832